Literature DB >> 24801552

Paclitaxel-coated balloons and aneurysm formation in peripheral vessels.

Athanasios Diamantopoulos1, Yuri Gupta2, Hany Zayed3, Konstantinos Katsanos3.   

Abstract

We report two cases of early aneurysmal vessel dilatation after a paclitaxel-coated balloon (PCB) was used for angioplasty of the peripheral vessels. The first case refers to a failing vein bypass with a tight proximal anastomotic stenosis, whereas the second refers to a distal tibial artery occlusion. A PCB was used to treat both patients. Aneurysmal dilatation of the previously treated segment was noted in both patients during subsequent follow-up imaging. In the absence of other causal factors, we attribute both cases to PCB application. The aneurysms that formed had no detrimental effect on the patients' health and required no further treatment; however, it is important to bear in mind this potential risk of presumed paclitaxel toxicity.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24801552     DOI: 10.1016/j.jvs.2014.03.291

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

Review 1.  Treating femoropopliteal disease: established and emerging technologies.

Authors:  Athanasios Diamantopoulos; Konstantinos Katsanos
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

2.  Long-term outcomes of paclitaxel-coated balloons for non-malignant ureteral strictures.

Authors:  Panagiotis Kallidonis; Stavros Spiliopoulos; Panagiotis Papadimatos; Constantinos Katsanos; Despoina Liourdi; Arman Tsaturyan; Dimitrios Karnabatidis; Evangelos Liatsikos; Panagiotis Kitrou
Journal:  World J Urol       Date:  2022-03-05       Impact factor: 4.226

3.  One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial.

Authors:  Zhichao Lai; Xin Zhang; Jiang Shao; Kang Li; Lijing Fang; Leyin Xu; Xiaoxi Yu; Jingjing Wang; Xiu Liu; Jinsong Lei; Bao Liu
Journal:  BMC Cardiovasc Disord       Date:  2020-02-06       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.